[Federal Register Volume 86, Number 150 (Monday, August 9, 2021)]
[Notices]
[Pages 43548-43549]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16954]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting: Advisory Board on Radiation and Worker Health (ABRWH), 
Subcommittee for Dose Reconstruction Reviews (SDRR), National Institute 
for Occupational Safety and Health (NIOSH)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Subcommittee for Dose 
Reconstruction Reviews (SDRR) of the Advisory Board on Radiation and 
Worker Health (ABRWH or the Advisory Board). This meeting is open to 
the public, but without a public comment period. The public is welcome 
to submit written comments in advance of the meeting, to the contact 
person below. Written comments received in advance of the meeting will 
be included in the official record of the meeting. The public is also 
welcomed to listen to the meeting by joining the audio conference 
(information below). The audio conference line has 150 ports for 
callers.

DATES: The meeting will be held on September 29, 2021, from 10:30 a.m. 
to 4:00 p.m., EDT. Written comments must be received on or before 
September 22, 2021.

ADDRESSES: You may submit comments by mail to: Sherri Diana, National 
Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS 
C-34, Cincinnati, Ohio 45226.
    Meeting Information: Audio Conference Call via FTS Conferencing. 
The USA toll-free dial-in number is 1-866-659-0537; the pass code is 
9933701.

FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated 
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24, 
Cincinnati, Ohio 45226, Telephone: (513) 533-6800; Toll Free 1(800)CDC-
INFO; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key

[[Page 43549]]

functions of the Advisory Board include providing advice on the 
development of probability of causation guidelines that have been 
promulgated by the Department of Health and Human Services (HHS) as a 
final rule; advice on methods of dose reconstruction, which have also 
been promulgated by HHS as a final rule; advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program; and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
(SEC). In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to CDC. NIOSH implements this 
responsibility for CDC.
    The Advisory Board's charter was issued on August 3, 2001, renewed 
at appropriate intervals, and rechartered under Executive Order 13889 
on March 22, 2020, and will terminate on March 22, 2022.
    Purpose: The Advisory Board is charged with (a) providing advice to 
the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advise the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class. SDRR was 
established to aid the Advisory Board in carrying out its duty to 
advise the Secretary, HHS, on dose reconstruction.
    Matters To Be Considered: The agenda will include discussions on 
the following dose reconstruction program quality management and 
assurance activities: Dose reconstruction cases under review from Set 
29, possibly including cases involving: Albuquerque Operations Office, 
Area IV of the Santa Susana Field Laboratory, Argonne National 
Laboratory-East, Argonne National Laboratory-West, Battelle 
Laboratories-King Avenue, Clarksville Modification Center, Feed 
Materials Production Center (FMPC), Fermi National Accelerator 
Laboratory, General Atomics, Hanford, Idaho National Laboratory, 
Lawrence Berkeley National Laboratory, Lawrence Livermore National 
Laboratory, Los Alamos National Laboratory, Mound Plant, Nevada Test 
Site, Oak Ridge Gaseous Diffusion Plant (K-25), Oak Ridge Institute for 
Science and Education, Oak Ridge National Laboratory (X-10), Pacific 
Northwest National Laboratory, Paducah Gaseous Diffusion Plant, Pantex 
Plant, Portsmouth Gaseous Diffusion Plant, Rocky Flats Plant, Savannah 
River Site, and/or Y-12 Plant. If time permits, there may also be 
discussion on professional judgement in response to the April 12, 2021 
SDRR report to the Advisory Board. Agenda items are subject to change 
as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-16954 Filed 8-6-21; 8:45 am]
BILLING CODE 4163-18-P